Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

The Forum Units Stakeholders for Safe Drinking Water in India ...

Actors Sumit Kaul, Sumeet Raghvan, Pankaj Berry, Jayesh Bharbhaya, and Sachin Parikh express their gratitude to Indian soldiers on Republic Day. They share inspiring stories, reflecting on the ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...

Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

In Madhya Pradesh, the central Indian state, Shivnarayan Dasana, a vegetable vendor, had never witnessed such many police officers arrive at his village.

The 60-year-old lives in Tarapur in the industrial town of Pithampur, known for its automobile and pharmaceutical factories.

Company has reported net profit after tax of Rs 898.10 Crore in latest quarter.The company’s top management includes Mr.Pankaj R Patel, Dr.Sharvil P Patel, Mr.Ganesh N Nayak, Mr.Mukesh M Patel, ...

Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences's Usnoflast receives Orphan Drug Designation from the USFDA for the treatment of Amyotrophic Lateral ...